Description:
Reuterina Junior Strawberry Child Health Probiotic 30 Chew Tablets

Detailed Description:
Composition: each Reuterina™ junior chew tablet contains a minimum of 100 million (1 x 108) live, freeze-dried colony forming units (CFU) lactobacillus reuteri Protectis® (strain DSM 17938) until expiry. Contains xylitol and isomalt. Customer care line: 011 075 8800. Marketed by: Ascendis Pharma. Manufactured by: BioGaia® probiotics grounded in evolution driven by science. Scheduling status: S0. Proprietary name (and dosage form): Reuterina™ junior (tablets). Excipients: calcium stearate, citric acid, isomalt, palm oil, strawberry flavouring, xylitol (sweetener). Pharmacological classification: D.30.4 pre- & probiotics. Pharmacological action: Probiotics inhibit the colonisation of pathogens in the digestive tract to normalise the microflora through the following actions: antibiosis competing for nutrients and binding sites, alteration of microbial metabolism and stimulation of immunity. Indications: Probiotics are used to assist in the treatment and prevention of conditions linked to an imbalance in the gastrointestinal microflora, such as diarrhoea, constipation, colic, regurgitation, urogenital infections and gum disease. Reuterina™ junior helps restore and maintain a healthy balance of intestinal flora in children, thereby improving the function thereof. Identification: Reuterina™ Junior tablets are cream coloured with faint spots. They are strawberry flavoured and chewable. Presentation: 3 foil blister strips, containing 10 tablets each, in an outer carton.

Pack size:
30 Tablets

Quantity in pack:
30

Marketing description:
Child health probiotic. Strawberry flavour. S0. Reuterina™ junior. 30 chew tablets. Lactobacillus reuteri Protection® (strain DSM 17938).

Brand:
Reuterina

Package type:
Box